ALLMedicine™ Pneumonectomy Center
Research & Reviews 983 results
https://doi.org/10.1007/s00586-022-07242-7 10.3171/2018.4.SPINE171389 10.1016/S0140-6736(08)60658-3 10.3390/ijerph18158152 10.3109/17453677408989697 10.1016/s0022-3468(85)80477-2 10.1097/00007632-199207000-00024 10.1542/peds.2008-3704 10.1016/s0022-3468(86)80007-0 10.1017/S1047951103000519 10.1097/00007632-199109000-00019 10.1302/0301-620X.54B2.230 10.1007/s00586-010-1563-y 10.2106/00004623-196951020-00002 10.1007/s00383-020-04683-3 10.1542/peds.2015-0709 10.1186/1748-7161-3-16 10.1007/s00595-016-1434-1 10.1007/s00383-020-04683-3 10.1007/s00586-011-1983-3 10.1007/s11832-012-0463-6 10.2106/00004623-199304000-00006 10.1016/j.athoracsur.2008.08.069 10.2106/00004623-198062070-00015 10.1007/s00246-009-9469-3 10.2106/JBJS.OA.17.00045 10.21037/atm.2019.11.134
European Spine Journal : Official Publication of the Euro... Sacco R, Bonnevalle M et. al.
May 21st, 2022 - To determine the midterm outcome of lateral thoracotomy (LT) in skeletally immature patients concerning thoracogenic scoliosis development and lung parenchyma resection (LPR) extent. In total, 129 children met the inclusion criteria: (1) LT during...
https://clinicaltrials.gov/ct2/show/NCT02959463
May 18th, 2022 - PRIMARY OBJECTIVES: I. To determine the safety and tolerability of pembrolizumab administered after radiation therapy in patients with malignant pleural mesothelioma (MPM) who have not undergone extrapleural pneumonectomy. SECONDARY OBJECTIVES: I....
https://doi.org/10.1093/icvts/ivac130
Interactive Cardiovascular and Thoracic Surgery; Chen X, Zhang Y et. al.
May 17th, 2022 - Ectopic ACTH syndrome(EAS) has historically been a therapeutic challenge because of difficulty localizing occult ACTH-secreting tumors. Here we report a case of a 67-year-old woman with EAS and had an ACTH-secreting tumour hidden within a congenit...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072017
Disease Markers; Xu J, Huang L et. al.
May 10th, 2022 - Surgical treatment is the first choice for non-small-cell lung cancer. To date, there are only few studies on the changes in laboratory indexes in two types of surgery, namely, thoracoscopic lobectomy and segmental pneumonectomy. To investigate th...
https://doi.org/10.1016/j.athoracsur.2022.03.079
The Annals of Thoracic Surgery; Brandt WS, Kozower BD
Apr 20th, 2022 - Are Sleeves the New-pneumonectomy?|2022|Brandt WS,Kozower BD,|
Guidelines 1 results
https://doi.org/10.1097/COC.0000000000000154
American Journal of Clinical Oncology; Willers H, Stinchcombe TE et. al.
Mar 25th, 2015 - The integration of chemotherapy, radiation therapy (RT), and surgery in the management of patients with stage IIIA (N2) non-small-cell lung carcinoma is challenging. The American College of Radiology (ACR) Appropriateness Criteria Lung Cancer Pane...
Clinicaltrials.gov 31 results
https://clinicaltrials.gov/ct2/show/NCT02959463
May 18th, 2022 - PRIMARY OBJECTIVES: I. To determine the safety and tolerability of pembrolizumab administered after radiation therapy in patients with malignant pleural mesothelioma (MPM) who have not undergone extrapleural pneumonectomy. SECONDARY OBJECTIVES: I....
https://clinicaltrials.gov/ct2/show/NCT04807153
Mar 22nd, 2022 - Pneumonectomy is a high risk surgical procedure compared to lobectomy, segmentectomy and non-anatomical resection. Pneumonectomy causes impairment of respiratory functions and exercise intolerance. Assessment of exercise capacity in pneumonectomy ...
https://clinicaltrials.gov/ct2/show/NCT03125798
Nov 8th, 2021 - Summary Surgical treatment of lung cancer consists of two elements: anatomical lung resection (segmentectomy, lobectomy or pneumonectomy) followed by mediastinal lymph node sampling (MLNS) or mediastinal lymph node dissection (MLND). Since over la...
https://clinicaltrials.gov/ct2/show/NCT03523468
Oct 19th, 2021 - In surgical treatment decisions, locally advanced central lung cancer is the most difficult. Locally advanced central lung cancer refers to tumors that have recidivised adjacent organs and tissues, such as the esophagus, tracheal carina, pericardi...
https://clinicaltrials.gov/ct2/show/NCT01644994
Sep 29th, 2021 - The aim is to introduce a new therapeutic method of intracavitary chemotherapy (cisplatin) combined with a fibrin carrier (Vivostat®) after pleurectomy/decortication or extrapleural pneumonectomy in a phase I and II study for Malignant Pleural Mes...
News 54 results
https://www.onclive.com/view/msk-continues-on-groundbreaking-path-in-treatment-of-mesothelioma
Oct 6th, 2021 - Prasad S. Adusumilli, MD Deputy Chief, Thoracic Service Memorial Sloan Kettering Cancer Center Although malignant pleural mesothelioma (MPM) remains a rare disease, Memorial Sloan Kettering Cancer Center has considerable experience with th...
https://www.onclive.com/view/adjuvant-atezolizumab-shows-improvement-in-dfs-time-to-relapse-in-pd-l1-stage-ii-iiia-nsclc-subgroups
Sep 20th, 2021 - Adjuvant treatment with atezolizumab (Tecentriq) led to an improvement in disease-free survival (DFS) and time to locoregional and distant relapse compared with best supportive care (BSC) in prespecified subgroups of PD-L1–positive patients with s...
https://www.onclive.com/view/novel-neoadjuvant-triplet-shows-preliminary-promise-in-resectable-pleural-mesothelioma
Sep 13th, 2021 - Neoadjuvant treatment with cisplatin/pemetrexed plus atezolizumab (Tecentriq), followed by maintenance atezolizumab, demonstrated early efficacy with acceptable safety in patients with resectable pleural mesothelioma, according to data from an upd...
https://www.medscape.com/viewarticle/958588
Sep 11th, 2021 - New data on the use of immunotherapy in early stages of non–small cell lung cancer (NSCLC) have sparked a debate on which patients benefit most. Previous results have already shown that patients with early-stage NSCLC who receive atezolizumab (Tec...
https://www.onclive.com/view/dr-spicer-on-outcomes-from-the-checkmate-816-trial-in-nsclc
Aug 20th, 2021 - Jonathan Spicer, MD, PhD, assistant professor of surgery, Dr. Ray Chiu Distinguished Scientist in Surgical Research; program director, Advanced Thoracic and Upper GI Surgical Oncology Fellowship; site lead, Rossy Cancer Network Lung Cancer Disease...
